Evidence-Based Complementary and Alternative Medicine

Research Article

The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy

Table 3

Network and annotation.
NetworkAnnotation
MyListhsa05161|Hepatitis B|−41.7; R-HSA-1280215|Cytokine Signaling in Immune system|−39.3; ko04933|AGE-RAGE signaling pathway in diabetic complications|−38.8
MyList_MCODE_ALLhsa05161|Hepatitis B|−47.8; hsa05200|Pathways in cancer |−46.3; WP4666|Hepatitis B infection|−42.3
MyList_SUB1_MCODE_1hsa05161|Hepatitis B|−22.8; hsa05200|Pathways in cancer |−20.8; ko04933|AGE-RAGE signaling pathway in diabetic complications|−20.5
MyList_SUB1_MCODE_2hsa05200|Pathways in cancer|−24.0; hsa05161|Hepatitis B|−23.3; ko05212|Pancreatic cancer|−22.9
MyList_SUB1_MCODE_3R-HSA-194315|Signaling by Rho GTPases|−3.5; R-HSA-1280215|Cytokine Signaling in Immune system|−3.5; R-HSA-9716542|Signaling by Rho GTPases, Miro GTPases, and RHOBTB3|−3.5
MyList_SUB1_MCODE_4R-HSA-1280215|Cytokine Signaling in Immune system|−4.2
MyList_SUB1_MCODE_5WP384|Apoptosis modulation by HSP70|−9.6; WP2507|Nanomaterial induced apoptosis|−9.5; M197|PID HIV NEF PATHWAY|−8.8